<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Cardiology &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/cardiology/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>ACE inhibitor treated hypertension linked to reduced all-cause mortality</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/</link>
		<pubDate>Wed, 16 May 2012 15:39:22 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[hypertension]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31830</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></description>
		
			<media:content duration="1:23" medium="video">
		<media:title><![CDATA[ACE inhibitor treated hypertension linked to reduced all-cause mortality]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516epid004.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,angiotensin,hypertension]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Aspirin use doesn&#8217;t curb peptic ulcer healing</title>
		<link>http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/</link>
		<pubDate>Tue, 15 May 2012 18:56:57 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[esomeprazole]]></category>
		<category><![CDATA[peptic ulcer]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31795</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></description>
		
			<media:content duration="1:34" medium="video">
		<media:title><![CDATA[Aspirin use doesn&#8217;t curb peptic ulcer healing]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin005.jpg"/>
	<media:keywords><![CDATA[aspirin,esomeprazole,peptic ulcer]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Good long-term survival after catheter valvotomy for pulmonary atresia</title>
		<link>http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/</link>
		<pubDate>Mon, 14 May 2012 17:19:50 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[catheter valvotomy]]></category>
		<category><![CDATA[Pulmonary atresia]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31748</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Good long-term survival after catheter valvotomy for pulmonary atresia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd002.jpg"/>
	<media:keywords><![CDATA[catheter valvotomy,Pulmonary atresia]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia</title>
		<link>http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/</link>
		<pubDate>Mon, 14 May 2012 16:24:41 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[NIPS]]></category>
		<category><![CDATA[Noninvasive programmed stimulation]]></category>
		<category><![CDATA[VT ablation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31744</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></description>
		
			<media:content duration="1:50" medium="video">
		<media:title><![CDATA[Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd001.jpg"/>
	<media:keywords><![CDATA[NIPS,Noninvasive programmed stimulation,VT ablation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Quality of life improves after transcatheter aortic valve implantation</title>
		<link>http://www.thedoctorschannel.com/view/quality-of-life-improves-after-transcatheter-aortic-valve-implantation/</link>
		<pubDate>Fri, 11 May 2012 20:57:46 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[TAVI]]></category>
		<category><![CDATA[transcatheter aortic valve implantation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31701</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Health-related quality of life (HRQOL) improves in the year after transcatheter aortic valve implantation (TAVI), researchers from UK and Germany find in 2 separate studies. “These findings are clinically significant, as improvement in both quality and quantity of life is important to patients and physicians,” Dr. John P. Greenwood from -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Quality of life improves after transcatheter aortic valve implantation]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Health-related quality of life (HRQOL) improves in the year after transcatheter aortic valve implantation (TAVI), researchers from UK and Germany find in 2 separate studies. “These findings are clinically significant, as improvement in both quality and quantity of life is important to patients and physicians,” Dr. John P. Greenwood from -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/quality-of-life-improves-after-transcatheter-aortic-valve-implantation/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120511clin009.jpg"/>
	<media:keywords><![CDATA[TAVI,transcatheter aortic valve implantation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Higher beta-blocker dose lowers mortality in heart failure patients</title>
		<link>http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/</link>
		<pubDate>Wed, 09 May 2012 21:43:01 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[beta-blocker]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31316</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></description>
		
			<media:content duration="1:27" medium="video">
		<media:title><![CDATA[Higher beta-blocker dose lowers mortality in heart failure patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120509clin001.jpg"/>
	<media:keywords><![CDATA[beta-blocker,Heart Failure]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Outcomes similar with on-pump or off-pump CABG in elderly patients</title>
		<link>http://www.thedoctorschannel.com/view/outcomes-similar-with-on-pump-or-off-pump-cabg-in-elderly-patients-2/</link>
		<pubDate>Tue, 08 May 2012 22:21:26 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[CABG]]></category>
		<category><![CDATA[elderly]]></category>
		<category><![CDATA[pump]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31269</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant difference in outcomes between on-pump and off-pump procedures in this population. “Both techniques are relatively safe and can be performed with a fairly low rate of major -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Outcomes similar with on-pump or off-pump CABG in elderly patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant difference in outcomes between on-pump and off-pump procedures in this population. “Both techniques are relatively safe and can be performed with a fairly low rate of major -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/outcomes-similar-with-on-pump-or-off-pump-cabg-in-elderly-patients-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120508clin001.jpg"/>
	<media:keywords><![CDATA[CABG,elderly,pump]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>New meta-analysis confirms benefits of radial approach for PCI</title>
		<link>http://www.thedoctorschannel.com/view/new-meta-analysis-confirms-benefits-of-radial-approach-for-pci/</link>
		<pubDate>Mon, 07 May 2012 22:26:59 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[transfemoral]]></category>
		<category><![CDATA[transradial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31088</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the transfemoral approach, a new systematic review and meta-analysis of relevant research confirms. In addition, a benefit of the transradial approach on the incidence of death or myocardial -]]></description>
		
			<media:content duration="1:32" medium="video">
		<media:title><![CDATA[New meta-analysis confirms benefits of radial approach for PCI]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the transfemoral approach, a new systematic review and meta-analysis of relevant research confirms. In addition, a benefit of the transradial approach on the incidence of death or myocardial -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/new-meta-analysis-confirms-benefits-of-radial-approach-for-pci/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120507clin001.jpg"/>
	<media:keywords><![CDATA[PCI,transfemoral,transradial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Lower BP guards against brain bleeds related to antithrombotic therapy</title>
		<link>http://www.thedoctorschannel.com/view/lower-bp-guards-against-brain-bleeds-related-to-antithrombotic-therapy/</link>
		<pubDate>Mon, 07 May 2012 21:34:40 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Antithrombotic]]></category>
		<category><![CDATA[bleeding]]></category>
		<category><![CDATA[blood pressure]]></category>
		<category><![CDATA[cerebrovascular disease]]></category>
		<category><![CDATA[stroke]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31086</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a subsidiary analysis of the Perindopril Protection Against Recurrent Stroke trial. In an email to Reuters Health, Dr. John Chalmers of The George Institute for Global Health, University -]]></description>
		
			<media:content duration="1:33" medium="video">
		<media:title><![CDATA[Lower BP guards against brain bleeds related to antithrombotic therapy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a subsidiary analysis of the Perindopril Protection Against Recurrent Stroke trial. In an email to Reuters Health, Dr. John Chalmers of The George Institute for Global Health, University -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/lower-bp-guards-against-brain-bleeds-related-to-antithrombotic-therapy/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120507clin002.jpg"/>
	<media:keywords><![CDATA[Antithrombotic,bleeding,blood pressure,cerebrovascular disease,stroke]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>New oral anticoagulants better than warfarin in AF patients</title>
		<link>http://www.thedoctorschannel.com/view/new-oral-anticoagulants-better-than-warfarin-in-af-patients/</link>
		<pubDate>Fri, 04 May 2012 19:22:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[intracranial bleeding]]></category>
		<category><![CDATA[pixaban]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[stroke]]></category>
		<category><![CDATA[warfarin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30973</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Results of a new meta-analysis indicate that for patients with atrial fibrillation, treatment with one of the new oral anticoagulants rather than warfarin is more effective for preventing stroke and less risky in terms of intracranial bleeding. “Overall, our results support the use of the new oral anticoagulants as alternatives -]]></description>
		
			<media:content duration="1:28" medium="video">
		<media:title><![CDATA[New oral anticoagulants better than warfarin in AF patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Results of a new meta-analysis indicate that for patients with atrial fibrillation, treatment with one of the new oral anticoagulants rather than warfarin is more effective for preventing stroke and less risky in terms of intracranial bleeding. “Overall, our results support the use of the new oral anticoagulants as alternatives -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/new-oral-anticoagulants-better-than-warfarin-in-af-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120504drgd006.jpg"/>
	<media:keywords><![CDATA[AF,atrial fibrillation,dabigatran,intracranial bleeding,pixaban,rivaroxaban,stroke,warfarin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
